doi: 10.1001/jama.2023.19574 [DOI] [PMC free article] [PubMed] [Google Scholar] 56.Jalleh RJ, Rayner CK, Hausken T, Jones KL, Camilleri M, Horowitz M
Seek clinics dedicated to providing ongoing support beyond the prescription
That's what makes today's launch personal," Geoff Cook, CEO of Noom, said in a LinkedIn post
More promising results, however, were announced the same month by Eli Lilly for its new once-daily GLP-1 pill which showed promise for weight management and for the treatment of type-2 diabetes
Here is what you should know
The STEP 4 trial, which specifically examined semaglutide withdrawal, showed that participants who stopped the medication regained 6.9% of body weight over 48 weeks, while those who continued treatment lost an additional 7.9%